Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Healthcare Industry News Can collagen peptides really control blood sugar? Darling Ingredients says yes! Darling Ingredients Inc. (NYSE: DAR) announced the publication of new research in the Wiley Journal of Food Science… byPallavi MadhirajuOctober 22, 2024